• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Early initiation of poststernotomy cardiac rehabilitation exercise training is effective and safe

byKeerthana PasumarthiandAlex Chan
July 4, 2022
in Cardiology, Surgery
Reading Time: 3 mins read
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery
Share on FacebookShare on Twitter

1. Early cardiac rehabilitation following cardiac surgery involving median sternotomy was non-inferior to usual-care cardiac rehabilitation, suggesting similar levels of effectiveness and safety amongst both groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: There have been significant improvements in post-operative care and reduced complication rates in patients who have cardiac surgery requiring median sternotomy. Despite this, cardiac rehabilitation is often not initiated until six weeks post-sternotomy due to concerns regarding sternal healing following surgery. There remains ambiguity around indications for activity following sternotomy with no clear clinical recommendations, although some evidence does suggest that overly restrictive sternal precautions may contribute to poor health outcomes and subsequently support the earlier initiation of cardiac rehabilitation. As such, this randomized clinical trial aimed to investigate the effectiveness and safety of cardiac rehabilitation (CR) started two weeks after sternotomy (early CR) compared to CR started six weeks after (usual-care CR). A total of 158 participants from the United Kingdom who had coronary artery bypass graft and mitral or aortic valve replacement, recovering from median sternotomy were included. Participants were randomly assigned to early CR or usual-care CR groups and change in 6-minute walk test distance from baseline to after CR was assessed in all participants. The results of this study showed that early CR was not inferior to usual-care CR. In conclusion, this trial indicates that in patients receiving cardiac surgery involving median sternotomy, early cardiac rehabilitation is just as effective as usual-care cardiac rehabilitation. However, as this study was only conducted in two hospitals within the United Kingdom, these findings may not be generalizable to the greater population. Nonetheless, this study offers insights into effectiveness and safety of the earlier initiation of CR and warrants further research investigating long-term health outcomes and psychosocial benefits of earlier CR.

Click here to read the study in JAMA Cardiology

Relevant Reading: Effects of 12-Week Supervised Early Resistance Training (SEcReT) Versus Aerobic-Based Rehabilitation on Cognitive Recovery Following Cardiac Surgery via Median Sternotomy: A Pilot Randomized Controlled Trial

In-Depth [Randomized Control Trial]: The present study used data from patients aged 18 to 90 who had coronary artery bypass graft and cardiac valve replacement or repair, recovering from median sternotomy at two hospitals in the United Kingdom. To examine the efficacy and safety of early cardiac rehabilitation compared to usual-care cardiac rehabilitation following cardiac surgery involving sternotomy, 158 participants recovering from sternotomy were included. Early cardiac rehabilitation (CR) was started at two weeks and usual-care cardiac rehabilitation was started at six weeks. In both groups, participants completed eight weeks of twice-weekly, one-hour CR exercise training. The usual-care CR group completed a warm-up with light cardiovascular and mobility exercises followed by moderate-intensity continuous cardiovascular exercises such as cycling, rowing, or walking on the treadmill. The early CR group began rehabilitation with an individualized exercise program dictated by their current level of fitness and post-surgery symptoms; these participants were slowly transitioned to usual-care CR exercises once they were able to tolerate this. Participants were randomly assigned to either early CR or usual-care CR. Primary outcomes for this study included change in the six-minute walk test distance from baseline to after rehabilitation. Secondary outcomes included safety, functional fitness, and quality of life. Statistical analyses included linear regression. The results of this study showed that early CR was not inferior to usual-care CR. The noninferiority margin was 35m and the average change in 6-minute walk test distance was 28m higher in the early CR group compared to the usual-care CR group (95%CI, -11-66, P=0.16). Additionally, there was no statistically different change in safety, functional fitness, and quality of life between the two groups. This paper confirms that starting cardiac rehabilitation as early as two weeks post-sternotomy is as effective and safe as beginning CR six weeks after. Further research investigating benefits of early CR on psychosocial health, long-term health outcomes, and overall quality of life may be helpful in the prognosis of cardiac surgery patients receiving sternotomy.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

Image: PD

©2022  2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Cardiac surgerycardiologythoracics
Previous Post

2 Minute Medicine Rewind July 4, 2022

Next Post

FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post

FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option

New genetic link in pulmonary arterial hypertension holds therapeutic promise

Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes

Stem cell transplant may be effective in sickle cell disease

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.